Equities Research Analysts’ Ratings Reiterations for August, 14th (AAUKY, AUXO, AZN, BCS, DE, DNDN, DNN, EAT, EPAY, OVTI)
Anglo American plc (NASDAQ:AAUKY) had its sell rating reissued by analysts at Liberum Capital.
Auxilio (NASDAQ:AUXO) had its outperform rating reissued by analysts at Zacks. The firm currently has a $2.00 target price on the stock. Zacks’ analyst wrote, ” AUXILIO manages and reduces printing costs for hospitals and facilities by providing on-site staff and vendor management. It is the only vender neutral provider. Its services are in high demand as clients’ budgets are squeezed and health care profitability is reduced. The company is rolling other IT services to sell its client base to increase the company TAM as well as increase margins. Its recent acquisition of Delphiis adds a new product, security services, to aid in HIPPA compliance.”
AstraZeneca plc (NYSE:AZN) had its neutral rating reaffirmed by analysts at Credit Suisse.
Barclays (NYSE:BCS) had its buy rating reissued by analysts at Espirito Santo Investment Bank Research.
Deere & Company (NYSE:DE) had its neutral rating reiterated by analysts at Zacks. Zacks currently has a $89.00 price target on the stock. Zacks’ analyst wrote, “Deere reported third-quarter 2014 earnings of $2.33 per share, down 9% year over year. Earnings, however, beat the Zacks Consensus Estimate of $2.19. Deere’s worldwide total sales dipped 5% year over year to $9.50 billion, surpassing the Zacks Consensus Estimate. Deere expects a 6% drop in equipment sales and lowered its net income projection to $3.1 billion for fiscal 2014. Deere’s long-term outlook remains strong based on increased global demand for food, shelter and infrastructure. Additionally, the company continues to increase dividends and repurchase shares on the basis of strong balance sheet. However, lower commodity prices remain the matter of concern. Thus, we are reaffirming our Neutral recommendation on Deere with a target price of $89.”
Dendreon (NASDAQ:DNDN) had its neutral rating reiterated by analysts at Zacks. The firm currently has a $1.50 target price on the stock. Zacks’ analyst wrote, “The news of a probable default by Dendreon was disappointing and pretty much eclipsed second quarter results. Although Dendreon has sufficient cash to meet its ordinary course obligations for at least the next twelve months, the company will surely not be able to repay or refinance its debt due in 2016. Dendreon reported a net loss of $0.10 in the second quarter of 2014, narrower than the Zacks Consensus Estimate of $0.18 and the year-ago loss of $0.45. Total revenue in the reported quarter was up 12.1% year over year to $82.2 million and beat the Zacks Consensus Estimate of $74 million. The departure of the company’s CEO further increases the uncertainty surrounding Dendreon. We maintain our Neutral recommendation on the stock.”
Denison Mines Corp (NYSE:DNN) had its speculative market perform rating reissued by analysts at BMO Capital Markets.
Brinker International (NYSE:EAT) had its rating reaffirmed by analysts at Tigress Financial.
Bottomline Technologies (NASDAQ:EPAY) had its sell rating reiterated by analysts at Off Wall Street.
OmniVision Technologies (NASDAQ:OVTI) had its fair value rating reissued by analysts at Needham & Company LLC.
Prudential Public Limited Company (NYSE:PUK) had its buy rating reiterated by analysts at Berenberg Bank.
Range Resources Corp. (NYSE:RRC) had its buy rating reaffirmed by analysts at Cantor Fitzgerald.
Wood Group John Plc (NASDAQ:WDGJF) had its outperform rating reissued by analysts at Credit Suisse.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.